| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $175.5M | +31.0% |
| Cost of Revenue | $14.1M | +149.8% |
| R&D Expense | $49.6M | +10.3% |
| SG&A Expense | $195.0M | -0.7% |
| Operating Income | -$91.7M | +17.7% |
| Interest Expense | $2.8M | — |
| Pre-tax Income | -$77.5M | +27.2% |
| Income Tax | $551K | -69.9% |
| Net Income | -$78.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.8M | -48.2% |
| Accounts Receivable | $24.1M | +78.7% |
| Inventory | $39.7M | +60.4% |
| Current Assets | $424.8M | -4.0% |
| Total Assets | $548.1M | +16.4% |
| Current Liabilities | $77.2M | +67.4% |
| Total Liabilities | $170.1M | +160.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.5M | +57.9% |
| Investing Cash Flow | -$6.7M | +88.9% |
| Financing Cash Flow | -$5.1M | -310.9% |
| +27.9% |
| EPS (Basic) | -$0.54 | +28.9% |
| EPS (Diluted) | -$0.54 | +28.9% |
| Stockholders' Equity |
| $378.0M |
| -6.8% |